Jeffrey L. Wade - Feb 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
President and CFO
Signature
/s/ Jeffrey L. Wade
Stock symbol
LXRX
Transactions as of
Feb 28, 2024
Transactions value $
-$98,750
Form type
4
Date filed
2/29/2024, 04:32 PM
Previous filing
Feb 12, 2024
Next filing
Jul 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +11.2K +4.23% 276K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +37.3K +13.53% 313K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +49.1K +15.7% 362K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Tax liability -$98.8K -37.7K -10.41% $2.62 324K Feb 28, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -11.2K -100% 0 Feb 28, 2024 Common Stock 11.2K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -37.3K -50% 37.3K Feb 28, 2024 Common Stock 37.3K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -49.1K -33.33% 98.2K Feb 28, 2024 Common Stock 49.1K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.